公司资料
Arcturus Therapeutics Holdings Inc. 股价、新闻与催化剂
- 股票代码:
- ARCT
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
8.14 USD (-1.09%)
收盘价
最后更新: 2026年8月17日
217M USD
市值
股价为何变动
As of Aug 17, 2026, ARCT closed down 1.09% at $8.14. No new same-company headline was identified in the current news window.
公司概览
业务概览
Arcturus Therapeutics is an RNA medicines company focused on mRNA and self-amplifying RNA technologies. Its story is built around platform science that aims to produce vaccines and therapeutics across multiple disease areas.
所在地与行业分类
Arcturus is headquartered in the United States and listed on NASDAQ. It sits in platform biotechnology with a strong RNA-technology identity.
商业模式特征
The company depends on platform validation, clinical progress, and the ability to convert RNA science into durable product revenue. Investors watch vaccine or therapeutic data, partnerships, and manufacturing capability.
生物医药行业定位
Arcturus occupies a platform-RNA niche within biotech. It is sensitive to whether self-amplifying RNA can create differentiated therapeutic value beyond the first wave of products.
未来催化剂
- Arcturus’s catalysts are mRNA-platform updates, vaccine and therapeutic development, and any partnership or clinical step that keeps the platform credible. The company still needs human proof.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。